Evidence review

BPC-157 and KPV: Preclinical Data on Gut Tissue Responses in Relation to Acid Suppression

#peptide#topic
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `bpc-kpv-ppi`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/bpc-kpv-ppi

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/bpc-kpv-ppi/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/bpc-kpv-ppi/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/bpc-kpv-ppi/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/bpc-kpv-ppi/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: KPV is studied for gut lining and inflammatory gut pathways — mucosal repair vs ongoing gut degeneration.

Why BPC-157 might help you

  1. What keeps failing: Poor blood supply at injury, weak collagen organization, slow tissue turnover.
  2. What BPC-157 is studied to do: Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.
  3. Therefore for you: If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.

Why KPV might help you

  1. Repair pathway: KPV is studied for gut lining and inflammatory gut pathways — mucosal repair vs ongoing gut degeneration.
  2. Therefore for you: If that layer is part of your problem, KPV is discussed because it targets repair (tissue) — not because it masks pain.

Why PPIs (omeprazole, etc.) matters for you

  1. Drug: PPIs (omeprazole, etc.)
  2. What it does: Acid suppression; long-term mucosal and nutrient consequences.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Each compound above targets a different degeneration layer. Together they are a stack — not five copies of the same mechanism.

  • BPC-157 → structure / tissue
  • KPV → gut / localized anti-inflammatory

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 6
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 13
  • Reddit posts catalogued: 12
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 1
  • Total sources in chain: 20

Quantified confidence (this ledger): 0.79 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Gastric pentadecapeptide body protection compound BPC 157 and wound healing (source s1)

Review of BPC-157 preclinical healing data across tissues including GI.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract (source s2)

Rat fistula and GI lesion healing results.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation (source s3)

Mouse colitis model demonstrating KPV anti-inflammatory effects.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Regeneration or Risk? A Narrative Review of BPC-157 (source s4)

Explicit confirmation of sparse human evidence for BPC-157.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

BPC-157 for GERD: Healing Esophagus & Stopping Acid Reflux (source s7)

Article discusses BPC-157 for GERD/esophagitis, explicitly addressing safe concurrent use with PPIs due to different mechanisms, with animal study references on sphincter repair and tissue healing; also notes stacking potential.

Evidence type: Published research.

Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review (source s8)

2025 review on BPC-157's pleiotropic effects in GI and other models, building on prior GI healing data without direct KPV/PPIs mention but relevant to peptide use in gut issues.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

BPC-157 Seems to be Helping : r/GERD — Reddit, r/GERD (source s5)

User reports BPC-157 healing GERD/esophagus issues, improved further with added KPV (and Larazotide), and successfully reduced/off PPIs for 2 months with only occasional use.

Has anyone ever tried the peptide BPC-157? : r/Gastritis — Reddit, r/Gastritis (source s6)

User on oral BPC-157 + KPV for gastritis reports calmer stomach, less inflammation; functional doctor recommends the combo for gut healing/inflammation, notes no side effects in 100+ patients.

Best peptides and brands for MCAS ? BPC-157, KPV and ... — Reddit, r/MCAS (source s9)

User anecdotes on BPC-157 + KPV stack for gut/MCAS symptoms (inflammation, GI issues); some mention context of acid-related or PPI-alternative needs indirectly via gut healing.

BPC157 and IBS — Reddit, r/bpc_157 (source s12)

Comment suggests combining BPC with KPV to help get off PPIs like Prilosec for IBS/acid issues; positive doctor-reported outcomes implied.

I’ve Had IBS My Whole Life. Sublingual BPC-157 Changed Everything — Reddit, r/ibs (source s13)

User reports no full relief from oral or injectable BPC-157; still required Omeprazole (PPI) alongside, mixed/poor outcome for gut symptoms.

BPC157 and IBS — Reddit, r/bpc_157 (source s14)

User planning to add KPV to BPC regimen after initial positive acid reflux relief while on PPI background.

BPC157 and Gut health — Reddit, r/bpc_157 (source s15)

User reports positive outcome with oral BPC-157 alongside omeprazole (PPI) for acid reflux and hiatal hernia; notes clear improvement from adding BPC. Another comment mentions negative GI upset from BPC and KPV.

Symptoms almost completely gone.....peptides have turned everything around — Reddit, r/LongCovid (source s16)

User reports using oral BPC-157 and KPV alongside PPI (and H2 blocker) for gastritis, implying positive experience in context of overall peptide success stories.

Acid blocker medication ruined my gut health. I have dysbiosis, thrush and anxiety from a PPI. Can bpc-157 help me?? — Reddit, r/bpc_157 (source s17)

User with PPI-related gut issues reports BPC-157 (injected) helping reduce reflux significantly, allowing reduced PPI use (from 2x/day to 1x/week). Not explicitly KPV but relevant to alongside PPIs.

BPC-157 oral and KPV for gastrointestinal issues — Reddit, r/ResearchCompounds (source s18)

User on pantoprazole (PPI) planning oral BPC-157 + KPV stack for ulcer/gastritis symptoms; no outcome reported yet.

So frustrated. Oral BPC seems to be making my symptoms worse — Reddit, r/bpc_157 (source s19)

User reports oral BPC-157 (in a gut peptide blend) worsened GERD/gastritis symptoms; comments suggest KPV as better alternative for GI and one user states 'Definitely made my stomach worse!'.

So frustrated. Oral BPC seems to be making my symptoms worse — Reddit, r/bpc_157 (source s20)

Direct user comment confirming negative experience with BPC for stomach issues (in context of GERD/gastritis thread).

What we do not know

  1. The full safety profile and potential long-term side effects of BPC-157 in human use, especially in conjunction with KPV or acid suppression therapies, remain largely unknown.

Safety and limits

  1. Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.

Peptide components (collapsible embeds)

BPC-157: Body Protection Compound · structure / tissue · bpc-157
{
  "peptide": "bpc-157",
  "regenerative_layer": "structure / tissue",
  "targets_this_degeneration": "Poor blood supply at injury, weak collagen organization, slow tissue turnover.",
  "proposed_regeneration": "Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.",
  "evidence_in_ledger": {
    "human_claims": 24,
    "preclinical_claims": 4,
    "anecdote_claims": 67,
    "studies_catalogued": 35
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/bpc-157"
}

Regeneration vs degeneration — where this fits The body breaks down tissue and builds it back at the same time. When breakdown stays ahead of repair, pain or weakness stays. Most drugs lower the pain or swelling signal without changing the damaged tissue. BPC-157 is studied for a different path: it is examined for step…

Full bpc-157 article →

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

PPIs · drug map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpKPV: Gut-Specific Anti-Inflammatory · 8 humanBPC-157 and KPV for IBD, Crohn's Disease, and Colitis: Preclinical Evi… · 7 humanBPC-157 + KPV for Gut Lining Repair: Evidence Review · 3 humanBenzo Withdrawal
Evidence · 20 sources · swipe →chain 1c82972ae53a · verify chain · provenance
1 / 20
Evidence ledger 24 · tier-ranked · API
mechanistic
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
human
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
system
BPC-157 and KPV: Preclinical Data on Gut Tissue Responses in Relation to Acid Suppression is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
humanlow confidence
2025 review on BPC-157's pleiotropic effects in GI and other models, building on prior GI healing data without direct KPV/PPIs mention but relevant to peptide use in gut issues.
sources: s8
humanlow confidence
The full safety profile and potential long-term side effects of BPC-157 in human use, especially in conjunction with KPV or acid suppression therapies, remain largely unknown.
sources: s4
15 more ranked claims
preclinical0.22low confidence
BPC-157 accelerates healing of gastrointestinal lesions and fistulas in rat models.
grok/4.3-populate
Establishes rat-specific gut repair observations separate from human data.
sources: s1, s2
preclinical0.22low confidence
KPV reduces intestinal inflammation via PepT1-mediated uptake in mouse colitis models.
grok/4.3-populate
Core preclinical mechanism for localized gut anti-inflammation.
sources: s3
anecdotal0.22low confidence
User reports BPC-157 healing GERD/esophagus issues, improved further with added KPV (and Larazotide), and successfully reduced/off PPIs for 2 months with only occasional use.
grok/grok-4.3
Materialized from orphan source s5 by ledger repair
sources: s5
anecdotal0.22low confidence
User on oral BPC-157 + KPV for gastritis reports calmer stomach, less inflammation; functional doctor recommends the combo for gut healing/inflammation, notes no side effects in 100+ patients.
grok/grok-4.3
Materialized from orphan source s6 by ledger repair
sources: s6
anecdotal0.22low confidence
User anecdotes on BPC-157 + KPV stack for gut/MCAS symptoms (inflammation, GI issues); some mention context of acid-related or PPI-alternative needs indirectly via gut healing.
grok/grok-4.3
Materialized from orphan source s9 by ledger repair
sources: s9
anecdotal0.22low confidence
Post links BPC-157 (with KPV mention) to addressing root causes masked by PPIs, for mucosal damage and permeability in gut/reflux contexts.
grok/grok-4.3
Materialized from orphan source s10 by ledger repair
sources: s10
anecdotal0.22low confidence
Comment suggests combining BPC with KPV to help get off PPIs like Prilosec for IBS/acid issues; positive doctor-reported outcomes implied.
grok/grok-4.3
Materialized from orphan source s12 by ledger repair
sources: s12
anecdotal0.22low confidence
User reports no full relief from oral or injectable BPC-157; still required Omeprazole (PPI) alongside, mixed/poor outcome for gut symptoms.
grok/grok-4.3
Materialized from orphan source s13 by ledger repair
sources: s13
anecdotal0.22low confidence
User planning to add KPV to BPC regimen after initial positive acid reflux relief while on PPI background.
grok/grok-4.3
Materialized from orphan source s14 by ledger repair
sources: s14
anecdotal0.22low confidence
User reports positive outcome with oral BPC-157 alongside omeprazole (PPI) for acid reflux and hiatal hernia; notes clear improvement from adding BPC. Another comment mentions negative GI upset from BPC and KPV.
grok-4.3
Materialized from orphan source s15 by ledger repair
sources: s15
anecdotal0.22low confidence
User reports using oral BPC-157 and KPV alongside PPI (and H2 blocker) for gastritis, implying positive experience in context of overall peptide success stories.
grok-4.3
Materialized from orphan source s16 by ledger repair
sources: s16
anecdotal0.22low confidence
User with PPI-related gut issues reports BPC-157 (injected) helping reduce reflux significantly, allowing reduced PPI use (from 2x/day to 1x/week). Not explicitly KPV but relevant to alongside PPIs.
grok-4.3
Materialized from orphan source s17 by ledger repair
sources: s17
anecdotal0.22low confidence
User on pantoprazole (PPI) planning oral BPC-157 + KPV stack for ulcer/gastritis symptoms; no outcome reported yet.
grok-4.3
Materialized from orphan source s18 by ledger repair
sources: s18
anecdotal0.22low confidence
User reports oral BPC-157 (in a gut peptide blend) worsened GERD/gastritis symptoms; comments suggest KPV as better alternative for GI and one user states 'Definitely made my stomach worse!'
grok-4.3
Materialized from orphan source s19 by ledger repair
sources: s19
anecdotal0.22low confidence
Direct user comment confirming negative experience with BPC for stomach issues (in context of GERD/gastritis thread).
grok-4.3
Materialized from orphan source s20 by ledger repair
sources: s20
Low-confidence / auto-generated 4
speculative0.12
Commercial vendors and clinics market this compound (10 commercial/clinic sources catalogued) — marketing material, not evidence.
commercial vendors
Collapsed 9 duplicate marketing claims
sources: s4, s11, s5, s6, s7, s9, s10, s12, s13, s14
speculative0.12
Article discusses BPC-157 for GERD/esophagitis, explicitly addressing safe concurrent use with PPIs due to different mechanisms, with animal study references on sphincter repair and tissue healing; also notes stacking potential.
grok/grok-4.3
Materialized from orphan source s7 by ledger repair
sources: s7
speculative0.12
A medical information website suggests BPC-157 may aid in healing esophageal damage and reducing acid reflux symptoms associated with GERD.
gemini-collaborator
This provides a specific example of a claim from a source type ('medical') that is distinct from user forums, adding nuance to the 'who claims what' category beyond general user reports.
sources: s7
speculative0.10
No published studies examine BPC-157 + KPV with PPIs or effects on acid suppression outcomes.
grok/4.3-populate
Highlights lack of data on the specific framing.
Model swipes · 16 from 6 models · swipe →verify
1 / 16
grok/grok-4.3writer
redraft2026-06-29 09:10
BPC-157 and KPV: Preclinical Data on Gut Tissue Responses in Relation to Acid Suppression · 4 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "bpc-157-kpv-alongside-ppis",
  "title": "BPC-157 and KPV: Preclinical Data on Gut Tissue Responses in Relation to Acid Suppression",
  "body": "## Overview of Key Peptides\n\nBPC-157 is a stable gastric pentadecapeptide derived from a gastric juice protein. In rat models of gastrointestinal injury, it has been associated with accelerated healing of intestinal anastomoses, fistulas, and various lesions (preclinical). \n\nKPV is a tripeptide with reported anti-inflammatory effects localized to the gut in mouse colitis models (preclinical).\n\n## Proton Pump Inhibitors and Acid Suppression\n\nPPIs reduce gastric acid production. No human data link BPC-157 or KPV to changes in PPI use or acid-related outcomes.\n\n## BPC-157 Evidence\n\n### Preclinical (Rat Studies)\n- BPC-157 accelerates healing of transected Achilles tendons and gastrointestinal lesions in rats (preclinical; PubMed studies).\n- It promotes angiogenesis and counters NSAID- or alcohol-induced gut damage in rat models (preclinical).\n- Limited human data exist overall; three small pilot studies (knee pain, interstitial cystitis, IV safety) show no direct relevance to gut repair or PPIs (human; very limited).\n\n### Mechanistic Notes\n- BPC-157 upregulates early growth response-1 (Egr-1) in cell and animal models (mechanistic).\n\n## KPV Evidence\n\n### Preclinical (Mouse/ Cell Studies)\n- KPV uptake via
e967e0119e4ddf97
grok-4.3source_hunt
sources2026-06-29 10:59
2 source(s) added · 2 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi
it output
5 source(s) added
b2d603cdac048751
grok-4.3source_hunt
sources2026-06-29 10:59
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi
it output
5 source(s) added
9001569a5e89d9f9
grok-4.3source_hunt
sources2026-06-29 11:00
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi
it output
3 source(s) added
54b291922899cc94
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi
it output
{"materialized":0,"before":[],"after":[]}
b8120d52494ccebf
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi
it output
{"materialized":0,"before":[],"after":[]}
9bd1a0e1977e6ee8
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi
it output
{"materialized":0,"before":[],"after":[]}
1ba64993784fb728
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi
it output
{"materialized":0,"before":[],"after":[]}
fac792717076926c
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi
it output
{"materialized":0,"before":[],"after":[]}
38ac47bcd330f701
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 13:39
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi
it output
I am adding claims to fill explicit gaps in the ledger and to specify who claims what from anecdotes, as instructed. I am not Grok because I am following the instructions to add specific types of claims rather than providing medical advice or inventing new URLs.
940ed2c47f531d80
gemini/gemini-2.5-flashcollaborator
collaborate2026-06-29 15:05
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi
it output
As Gemini, I've identified and added two tier-honest claims to address explicit gaps in the ledger, focusing on 'what_is_unknown' regarding human safety and 'who_claims_what' from a specific type of source. I've also challenged an existing claim that contains factual inaccuracies based on the provided topology. I am not Grok, as my rationale is based on specific instructions and data analysis, not a general persona.
0b0a995817feac57
grok-4.3source_hunt
sources2026-06-29 16:16
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi
it output
3 source(s) added
7d2bc4b787dea425
grok-4.3source_hunt
sources2026-06-29 16:17
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi
it output
3 source(s) added
1d989bd957b07d21
grok/grok-4.3editor
synthesize_body2026-06-29 16:30
synthesize_body
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi
it output
## Regeneration vs degeneration — where this fits
The body repairs gut lining while acid and inflammation break it down. When repair falls behind, symptoms like reflux or gastritis stay. Acid suppression drugs lower acid signals but do not rebuild tissue. BPC-157 and KPV are studied for repair steps: new vessel growth, cell migration to damaged areas, and reduced local inflammation in the gut.

## What it is
BPC-157 is a 15-amino-acid chain first found in human stomach fluid. KPV is a 3-amino-acid fragment from alpha-MSH. Both are examined in lab and animal work for gut tissue responses. No human dosing data appear in the ledger.

## How it works
Step 1: BPC-157 is linked to faster closure of gut lesions and fistulas in rat models.  
Step 2: KPV enters gut cells through PepT1 transporters and lowers inflammatory signals in mouse colitis.  
Step 3: These actions occur on separate pathways from acid-blocking drugs. The ledger shows no shared mechanism data with proton pump inhibitors.

## Why it would work (logic chain)
If gut lining breaks faster than it rebuilds, symptoms continue. If BPC-157 speeds lesion closure in rats and KPV cuts inflammation in mice, then both could shift the balance toward repair. If repair improves, the need for ongoing acid suppression might change. The ledger contains no human proof of this chain.

## Why people take it
People report trying the pair f
20352d37cef36a30
fill-slotsclaim_post
claim2026-06-29 21:04
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi c32
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
a43385ab0ef89d32
fill-slotsclaim_post
claim2026-06-29 21:04
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-kpv-ppi c32
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
9ee43184aff0b877

Related research

PPIs · drug map

Open evidence map →
KPV: Gut-Specific Anti-Inflammatoryembedded in this articlekpvBPC-157: Body Protection Compoundembedded in this articlebpc-157BPC-157 + KPV for Gut Lining Repair: Evidence Reviewembedded in this articlebpc-kpv-gut-repairBPC-157 for Long-Term PPI Users: Evidence Reviewembedded in this articlebpc-157-ppiBPC-157 and KPV for IBD, Crohn's Disease, and Colitis: Preclinical Evi…bpc-kpv-ibd-crohns-colitisBenzo Withdrawalkpv-benzo-withdrawalBenzodiazepineskpv-benzodiazepinesBrain Fogkpv-brain-fogCarpal Tunnelkpv-carpal-tunnelChemokpv-chemo
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. N…"?
ask bpc-kpv-ppi claim c32 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask bpc-kpv-ppi claim c19 · paste includes §SELF
What does the ledger say about this (system tier): "BPC-157 and KPV: Preclinical Data on Gut Tissue Responses in Relation to Acid Suppression is catalogued in this miscsubjects ledger as a tie…"?
ask bpc-kpv-ppi claim c31 · paste includes §SELF
What does the ledger say about this (human tier): "2025 review on BPC-157's pleiotropic effects in GI and other models, building on prior GI healing data without direct KPV/PPIs mention but r…"?
ask bpc-kpv-ppi claim c8 · paste includes §SELF
What does the ledger say about this (human tier): "The full safety profile and potential long-term side effects of BPC-157 in human use, especially in conjunction with KPV or acid suppression…"?
ask bpc-kpv-ppi claim c23 · paste includes §SELF
What does the ledger say about this (preclinical tier): "BPC-157 accelerates healing of gastrointestinal lesions and fistulas in rat models."?
ask bpc-kpv-ppi claim c1 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User reports BPC-157 healing GERD/esophagus issues, improved further with added KPV (and Larazotide), and successfully r"
ask bpc-kpv-ppi source s5 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User on oral BPC-157 + KPV for gastritis reports calmer stomach, less inflammation; functional doctor recommends the com"
ask bpc-kpv-ppi source s6 · paste includes §SELF
bpc-kpv-ppi · posted 2026-06-29 · updated 2026-06-29 · 23 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 23 model passes · 15738 tokens · $0 · 7 models
chain head 17ab1adbfb4d37f6
write grok/grok-4.3 · 2026-06-29 09:10 · 0 tok · 28a4cf66f22b
sources grok-4.3 · 2026-06-29 10:59 · 0 tok · dff9592d9264
sources grok-4.3 · 2026-06-29 10:59 · 0 tok · b38d4a8f0c96
sources grok-4.3 · 2026-06-29 11:00 · 0 tok · bd443b02c836
repair system/audit-repair · 2026-06-29 12:48 · 0 tok · 5aa9fa77260c
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · 613dc48bbc59
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · c9d085fbe03f
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · 17962042c40a
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · 1b2e8044b65c
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · 1451b6affc80
repair system/audit-repair · 2026-06-29 12:48 · 0 tok · 9a0fa8686e70
repair system/audit-repair · 2026-06-29 13:23 · 0 tok · 5febd910cb2b
repair system/audit-repair · 2026-06-29 13:23 · 0 tok · efe886858594
collaborate kimi/moonshot-v1-8k · 2026-06-29 13:39 · 3761 tok · 1b111ae14474
repair system/audit-repair · 2026-06-29 13:54 · 0 tok · 06bd7bfda546
repair system/audit-repair · 2026-06-29 13:54 · 0 tok · 480a37c638aa
collaborate gemini/gemini-2.5-flash · 2026-06-29 15:05 · 3439 tok · 0e550ad97bf8
sources grok-4.3 · 2026-06-29 16:16 · 0 tok · 98c5cc8d5e9b
sources grok-4.3 · 2026-06-29 16:17 · 0 tok · 4844071d5e1c
synthesize_body grok/grok-4.3 · 2026-06-29 16:30 · 8538 tok · ef2e932cb301
repair repair · 2026-06-29 19:53 · 0 tok · 53e9056e125a
claim fill-slots · 2026-06-29 21:04 · 0 tok · de748d13baf7
claim fill-slots · 2026-06-29 21:04 · 0 tok · 17ab1adbfb4d
verify chain →
Live ledger · 28 payloads · 7 turns
recent activity · inspect
PROTOCOL_RUN dispatch · 2026-06-29 18:19 · t_6q2uufbp
PROTOCOL_RUN dispatch · 2026-06-29 18:19 · t_6q2uufbp
PROTOCOL_RUN dispatch · 2026-06-29 16:17 · t_47b0d8xq
PROTOCOL_RUN dispatch · 2026-06-29 16:17 · t_47b0d8xq
webhook_in blooio · 2026-06-29 16:17
webhook_in blooio · 2026-06-29 16:17
view full ledger & cards →
REST + ledger
read GET /api/articles/bpc-kpv-ppi · GET /api/articles/bpc-kpv-ppi?format=post (the editable body)
create/replace POST /api/articles/bpc-kpv-ppi · PUT /api/articles/bpc-kpv-ppi (replace, keeps revision) · PATCH /api/articles/bpc-kpv-ppi (merge)
delete DELETE /api/articles/bpc-kpv-ppi
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/bpc-kpv-ppi/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/bpc-kpv-ppi/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim bpc-kpv-ppi|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →